Skip to content

Clinical study of phage salvage therapy for drug-resistant Acinetobacter baumannii infection

Clinical study of phage salvage therapy for drug-resistant Acinetobacter baumannii infection

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400093707
Enrollment
Unknown
Registered
2024-12-10
Start date
2025-01-01
Completion date
Unknown
Last updated
2024-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drug-resistant acinetobacter baumannii infection

Interventions

Sponsors

Ningxia Medical University General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: ? Patients infected with drug-resistant Acinetobacter baumannii (based on the drug sensitivity test results of our hospital or a hospital above 3A); ? The pathogenic bacteria infected by the patient (Acinetobacter baumannii) should meet one of the following conditions: 1) The pathogen is completely resistant to antibiotics; 2) Pathogen resistance to key antibiotics: resistance to carbapenems or third-generation and above cephalosporin antibiotics. 3) The pathogen is sensitive to the key antibiotics in vitro, but the antibiotic is clinically ineffective or ineffective (the effect is not obvious defined as the clinical effect is not obvious, the condition is not improved or worsened, and the microbial treatment is ineffective (the pathogen cannot be cleared)); 4) The pathogen is limited in the use of critical sensitive antibiotics (such as organ toxicity or patients allergic to this antibiotic); ? At least one lytic phage can be screened (virtual matching is not required); ? It can be administered by spraying, external application, atomizing inhalation, perfusion, local injection or diversion tube through infected foci; ? The subjects and their family members (or guardians) fully read, understand and sign the informed consent.

Exclusion criteria

Exclusion criteria: ? Bacterial infection can be effectively controlled by antibiotic treatment; ? There is no other route of administration except intravenous administration; ? Patients who were determined by the investigators to be unsuitable for participation in this study.

Design outcomes

Primary

MeasureTime frame
Bacterial culture and identification results;

Secondary

MeasureTime frame
Clinical Outcomes;

Countries

China

Contacts

Public ContactYang Xiaojun

Ningxia Medical University General Hospital

yxjicu@163.com+86 138 9510 1220

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026